## Abstract Previous studies have shown that epidermal growth factor (EGF) stimulates bone resorption in organ culture via a prostaglandinβmediated pathway, and that there are specific receptors for EGF on mouse bone (Tashjian and Levine, β²78; Shupnik et al., β²80). The present study demonstrates th
Dissection of Functional Sites on the Receptor for Epidermal Growth Factor
β Scribed by J.V. Staros; C.A. Guyer
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 559 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0045-2068
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Institute for Diabetes and Endocrinology, La lolla, California 92(1.?7 Treatment of Swiss 3T3 fibroblasts with basic fibroblast growth factor (bFGF) lead to a rapid reduction in epidermal growth factor (EGF) binding and a slower inhibition of EGF receptor autophosphorylation. The reduction in bindi
An enzyme-linked immunosorbent assay (ELISA) for the epidermal growth factor (EGF) receptor was developed using three different antibody preparations, one of which is commercially available. Using one of the antisera (986), the assay could detect as few as 200 x lo6 receptors. This is equal to 0.332
The receptor for epidermal growth factor (EGF) is a glycosylated transmembrane phosphoprotein that exhibits EGF-stimulable protein tyrosine kinase activity. On EGF stimulation, the receptor undergoes a self-phosphorylation reaction at tyrosine residues located primarily in the extreme carboxyl-termi
Transforming growth factor-alpha (TGFβ£) is an epidermal growth factor receptor (EGFR) ligand which is distinguished from EGF by its acid-labile structure and potent transforming function. We recently reported that TGFβ£ induces less efficient EGFR heterodimerization and downregulation than does EGF (